The Beauty and Joy of Computing

Economics 119, 001 - Fall 2013 Creative Commons 3.0: Attribution-NonCommercial-NoDerivs

On April 25, World Malaria Day, the non-profit Zagaya released a video showing why, in the words of UC Berkeley synthetic biologist Jay Keasling, "it took a village" to create an accessible treatment for malaria that will be essential to eradicating the disease. Sparked 12 years ago by a eureka moment in Keasling's UC Berkeley lab, the new treatment -- a semi-synthetic version of the proven antimalarial artemisinin -- resulted from the combined work of biotech firm Amyris, the Institute for OneWorld Health and the pharmaceutical firm Sanofi. The Bill and Melinda Gates Foundation provided $50 million to fund the work. On April 11, the team members celebrated a milestone in the fight against malaria: Sanofi's release of the semi-synthetic artemisinin. Full story: NewsCenter.berkeley.edu

eCHEM 1A: Online General Chemistry College of Chemistry, University of California, Berkeley http://chemistry.berkeley.edu/echem1a Curriculum and ChemQuizzes developed by Dr. Mark Kubinec and Professor Alexander Pines Chemical Demonstrations by Lonnie Martin Video Production by Jon Schainker and Scott Vento Developed with the support of The Camille & Henry Dreyfus Foundation